
BRASILIA, Brazil (AP) — Brazil’s former President Jair Bolsonaro was discharged from a hospital in the capital on Friday to continue serving a 27-year sentence for a coup attempt at his residence in an upscale gated community.
The Supreme Court earlier in the week granted him the right of house imprisonment due to failing health. The measure could be revised within 90 days.
Bolsonaro left the hospital DF Star in Brasilia at around 10 a.m. local time and headed to the Jardim Botanico neighborhood, where he lived prior to his conviction with his wife, Michelle Bolsonaro, and his 15-year-old daughter, Laura.
The 71-year-old was hospitalized on March 13 for pneumonia, one of several health issues he has faced since he was stabbed by a man in 2018 before being elected president. He was put in intensive care for days due to kidney and inflammatory problems.
Bolsonaro governed between 2019 and 2022 and narrowly lost his reelection bid to current President Luiz Inácio Lula da Silva.
latest_posts
- 1
Israeli president concerned over proposed renaming of park - 2
Novartis to build manufacturing hub in North Carolina, creating 700 jobs - 3
Death toll from floods in Afghanistan rises to 61 - 4
South America's Memorable Destinations: A Movement Guide - 5
Manual for Famous people Known for Their Altruistic Endeavors
Putin critic gets six years in penal colony, vows hunger strike
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it.
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
Famous Places to get-away for Americans
Solar storms have influenced our history – an environmental historian explains how they could also threaten our future
Scientists captured female sperm whales on video working together during a birth to protect the calf
Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial













